PALISADE BIO, INC. (PALI)
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Founded
2011
Number of Employees
9
Website
http://www.palisadebio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)